Perspectives in Urology: Point-Counterpoint Archives

nmCRPC: Is Navigating the M0 Space the Next Moon Shot?

Posted by E. David Crawford, MD | Dec 2019

E. David Crawford, MD, presented this lecture during the 28th Annual Perspectives in Urology: Point-Counterpoint on November 16, 2019, in Scottsdale, New Arizona.

Muscle Invasive Bladder Cancer: 2018 Guidelines

Posted by Michael S. Cookson, MD, MMHC | Jun 2019

Michael S. Cookson, MD, MMHC, outlines the purpose, methodology, and background for recently released guidelines for treating muscle invasive bladder cancer, including cisplatin-based chemotherapy. He highlights recommendation statements regarding patient counseling, neoadjuvant/adjuvant chemotherapy, radical cystectomy, pelvic lymphadenectomies, and more.

Scottsdale Prostate Cancer Symposium 2019

Posted by David Utz | Jun 2019

Presentations from Southwest Prostate Cancer Symposium 2019 SESSION I: Early Detection and Staging Screening for Prostate Cancer: PSA: Why 1.5 is the New 4.0 E. David Crawford, MD, presented this lecture during the 24th Annual...

Timing and Optimization of Radium 223 in CRPC

Posted by Phillip J. Koo, MD | Jun 2019

Phillip J. Koo, MD, briefly reviews several clinical trials examining the use of radium 223, focusing on its use in combination with second generation AR inhibitors. He also reviews the data from the ERA 223 trial that was recently reported at ESMO 2018 and discuss lessons learned, including the optimal use of radium 223 in patients with endocrine resistant prostate cancer.

Emerging Indications for a Novel Absorbable Hydrogel Spacer: A 2018 Review

Posted by Steven E. Finkelstein, MD, FACRO | Jun 2019

Steven E. Finkelstein, MD, FACRO, describes how hydrogel spacing is becoming standard of care for prostate cancer radiotherapy. He reviews the clinical investigations of adjacent prostate indications, as well as indications in other organs throughout the body, for this technology.